- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Anthony Slonim Highlights the Benefits of AJMC's ACO Coalition
Given the diverse stakeholders in attendance, the hallway conversations at the ACO and Emerging Healthcare Delivery Coalition Spring 2015 meeting in San Diego, California, were just as interesting as the sessions, according to Anthony D. Slonim, MD, DrPH, president and chief executive officer for Renown Health, and co-chair of Coalition.
Given the diverse stakeholders in attendance, the hallway conversations at The American Journal of Managed Care's ACO and Emerging Healthcare Delivery Coalition Spring 2015 meeting in San Diego, California, were just as interesting as the sessions, according to Anthony D. Slonim, MD, DrPH, president and chief executive officer for Renown Health, and co-chair of Coalition.
At the third live ACO Coalition event, there was more focus on disease-specific focus areas, he said, and this is incredibly important as the healthcare industry segments the population.
"I found that the AJMC Coalition has been a great opportunity for me to network professionally, and learn from other people who are doing the same kinds of work that I am," Dr Slonim said.
Learn more about the ACO Coalition and find out how to join and attend future events: click here.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
